Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1940 2
1945 1
1946 1
1948 1
1949 1
1950 3
1951 2
1952 5
1953 5
1954 2
1955 4
1956 3
1957 7
1958 6
1959 3
1960 6
1961 4
1962 5
1963 5
1964 1
1965 5
1966 1
1967 4
1968 3
1969 4
1970 5
1971 3
1972 5
1973 5
1974 5
1975 9
1976 6
1977 8
1978 10
1979 4
1980 7
1981 7
1982 2
1983 3
1984 9
1985 3
1986 9
1987 8
1988 10
1989 4
1990 6
1991 5
1992 13
1993 15
1994 15
1995 20
1996 24
1997 31
1998 32
1999 29
2000 32
2001 45
2002 43
2003 48
2004 65
2005 63
2006 85
2007 115
2008 126
2009 184
2010 218
2011 283
2012 313
2013 326
2014 412
2015 447
2016 528
2017 570
2018 674
2019 751
2020 892
2021 971
2022 1157
2023 1179
2024 1390
2025 637

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,701 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9 therapeutics: progress and prospects.
Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, He X, Liu M, Li PF, Yu T. Li T, et al. Among authors: yu t. Signal Transduct Target Ther. 2023 Jan 16;8(1):36. doi: 10.1038/s41392-023-01309-7. Signal Transduct Target Ther. 2023. PMID: 36646687 Free PMC article. Review.
Emerging therapies in cancer metabolism.
Xiao Y, Yu TJ, Xu Y, Ding R, Wang YP, Jiang YZ, Shao ZM. Xiao Y, et al. Among authors: yu tj. Cell Metab. 2023 Aug 8;35(8):1283-1303. doi: 10.1016/j.cmet.2023.07.006. Cell Metab. 2023. PMID: 37557070 Free article. Review.
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia.
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Pagel JM, Flinn IW, Kamdar M, Munir T, Walewska R, Corbett G, Fogliatto LM, Herishanu Y, Banerji V, Coutre S, Follows G, Walker P, Karlsson K, Ghia P, Janssens A, Cymbalista F, Woyach JA, Ferrant E, Wierda WG, Munugalavadla V, Yu T, Wang MH, Byrd JC. Sharman JP, et al. Among authors: yu t. Leukemia. 2022 Apr;36(4):1171-1175. doi: 10.1038/s41375-021-01485-x. Epub 2022 Jan 1. Leukemia. 2022. PMID: 34974526 Free PMC article. No abstract available.
Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior.
Harris HK, Nakayama T, Lai J, Zhao B, Argyrou N, Gubbels CS, Soucy A, Genetti CA, Suslovitch V, Rodan LH, Tiller GE, Lesca G, Gripp KW, Asadollahi R, Hamosh A, Applegate CD, Turnpenny PD, Simon MEH, Volker-Touw CML, Gassen KLIV, Binsbergen EV, Pfundt R, Gardeitchik T, Vries BBA, Immken LL, Buchanan C, Willing M, Toler TL, Fassi E, Baker L, Vansenne F, Wang X, Ambrus JL Jr, Fannemel M, Posey JE, Agolini E, Novelli A, Rauch A, Boonsawat P, Fagerberg CR, Larsen MJ, Kibaek M, Labalme A, Poisson A, Payne KK, Walsh LE, Aldinger KA, Balciuniene J, Skraban C, Gray C, Murrell J, Bupp CP, Pascolini G, Grammatico P, Broly M, Küry S, Nizon M, Rasool IG, Zahoor MY, Kraus C, Reis A, Iqbal M, Uguen K, Audebert-Bellanger S, Ferec C, Redon S, Baker J, Wu Y, Zampino G, Syrbe S, Brosse I, Jamra RA, Dobyns WB, Cohen LL, Blomhoff A, Mignot C, Keren B, Courtin T, Agrawal PB, Beggs AH, Yu TW. Harris HK, et al. Among authors: yu tw. Genet Med. 2021 Jun;23(6):1028-1040. doi: 10.1038/s41436-021-01114-z. Epub 2021 Mar 3. Genet Med. 2021. PMID: 33658631 Free PMC article.
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
Brown JR, Seymour JF, Jurczak W, Aw A, Wach M, Illes A, Tedeschi A, Owen C, Skarbnik A, Lysak D, Eom KS, Šimkovič M, Pavlovsky MA, Kater AP, Eichhorst B, Miller K, Munugalavadla V, Yu T, de Borja M, Ghia P; AMPLIFY investigators; AMPLIFY Investigators. Brown JR, et al. Among authors: yu t. N Engl J Med. 2025 Feb 20;392(8):748-762. doi: 10.1056/NEJMoa2409804. Epub 2025 Feb 5. N Engl J Med. 2025. PMID: 39976417 Clinical Trial.
Open Scapulothoracic Dissociation.
Chen YR, Xu B, Yu TF, Lu YN, Liang XZ, Liu CQ, Wang MX, Zhou B. Chen YR, et al. Among authors: yu tf. J Am Acad Orthop Surg Glob Res Rev. 2025 Mar 11;9(3):e24.00050. doi: 10.5435/JAAOSGlobal-D-24-00050. eCollection 2025 Mar 1. J Am Acad Orthop Surg Glob Res Rev. 2025. PMID: 40080695 Free PMC article.
Roles of ginsenosides in sepsis.
Yu T, Tang Y, Zhang F, Zhang L. Yu T, et al. J Ginseng Res. 2023 Jan;47(1):1-8. doi: 10.1016/j.jgr.2022.05.004. Epub 2022 May 7. J Ginseng Res. 2023. PMID: 36644389 Free PMC article. Review.
Epigenomic and phenotypic characterization of DEGCAGS syndrome.
Karimi K, Weis D, Aukrust I, Hsieh TC, Horackova M, Paulsen J, Mendoza Londono R, Dupuis L, Dickson M, Lesman H, Lau T, Murphy D, Hama Salih K, Al-Musawi BMS, Al-Obaidi RGY, Rydzanicz M, Biela M, Santos MS, Aldeeri A, Gazda HT, Pais L, Shril S, Døllner H, Bartakke S, Laccone F, Soltysova A, Kitzler T, Soliman NA, Relator R, Levy MA, Kerkhof J, Rzasa J, Houlden H, Pilshofer GV, Jobst-Schwan T, Hildebrandt F, Sousa SB, Maroofian R, Yu TW, Krawitz P, Sadikovic B, Douzgou Houge S. Karimi K, et al. Among authors: yu tw. Eur J Hum Genet. 2024 Dec;32(12):1574-1582. doi: 10.1038/s41431-024-01702-y. Epub 2024 Oct 19. Eur J Hum Genet. 2024. PMID: 39424669
10,701 results
You have reached the last available page of results. Please see the User Guide for more information.